SANUWAVE Health, Inc. researches, develops, and commercializes noninvasive, high-energy,and acoustic shock waves for regenerative medicine. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses.
